Prochlorperazine is a medication used primarily to control severe nausea and vomiting. It also has approved uses for treating schizophrenia and short-term anxiety, and it’s widely used in emergency rooms as a go-to treatment for acute migraines. You may recognize it by the brand names Compro or the now-discontinued Compazine, and it comes as an oral tablet or a rectal suppository.
Nausea and Vomiting
The most common reason people are prescribed prochlorperazine is severe nausea and vomiting. This includes nausea from surgery, chemotherapy, radiation, and other medical causes. It works by blocking dopamine receptors in the brain, specifically in the area that triggers the vomiting reflex. It also affects histamine and other chemical signaling pathways, which adds to its anti-nausea effects.
For nausea relief, prochlorperazine is available as a tablet you swallow or a suppository, which is especially useful when you’re too nauseated to keep a pill down. This isn’t a medication for mild, everyday stomach upset. It’s designed for nausea severe enough that it interferes with your ability to eat, drink, or function normally.
Migraine Relief
One of prochlorperazine’s most notable uses isn’t on its official label at all. Emergency departments frequently use it as a first-line treatment for acute migraines, particularly when nausea is part of the picture. The evidence behind this is strong: in one randomized trial, 90% of patients who received prochlorperazine had complete or partial migraine relief. In another study, three quarters of treated patients had complete nausea relief.
Head-to-head comparisons show prochlorperazine outperforms several other common migraine treatments, including magnesium, valproate, ketorolac (an anti-inflammatory), and metoclopramide (another anti-nausea drug). Some evidence suggests it may even work better than sumatriptan, one of the most widely prescribed migraine-specific medications. Neurologists consider prochlorperazine one of the best first-line options for migraine in the emergency setting.
Schizophrenia and Short-Term Anxiety
Prochlorperazine belongs to a class of older psychiatric medications called first-generation antipsychotics. It’s approved for treating schizophrenia, though newer antipsychotics have largely replaced it for that purpose. For milder symptoms, typical use involves lower doses taken three or four times daily. More severe cases in supervised settings may require significantly higher doses, adjusted gradually based on how a person responds.
It also has a lesser-known approval for short-term anxiety that isn’t related to a psychotic disorder. This use is limited to no more than 12 weeks and relatively low doses. It’s not a common choice for anxiety today, given the availability of other options with fewer side effects, but it remains an officially approved indication.
How It Works in the Body
Prochlorperazine’s main action is blocking dopamine D2 receptors in the brain. Dopamine plays a role in the brain’s vomiting center, in pain signaling (relevant to migraines), and in the thought patterns disrupted by psychotic disorders. By dampening dopamine activity in these areas, a single medication can address what seem like very different problems.
Beyond dopamine, prochlorperazine also blocks histamine receptors (which contributes to its sedating quality) and certain receptors involved in the body’s “rest and digest” nervous system. This broad chemical profile explains both its versatility and its range of side effects.
Common Side Effects
Because prochlorperazine blocks dopamine broadly, not just in the areas you’d want it to, it can cause movement-related side effects that range from uncomfortable to serious. These are called extrapyramidal symptoms, and they’re notably common with this drug. Studies report that between 25% and 67% of people taking prochlorperazine experience some form of these effects, a rate considerably higher than similar anti-nausea medications.
The movement side effects fall into a few categories:
- Dystonia: sudden, involuntary muscle contractions that can cause awkward postures or twisting movements, most often in the neck, face, or back. This typically appears within the first 48 hours in half of cases, and within five days in 90%.
- Akathisia: an intense internal restlessness and an irresistible urge to move, often showing up as leg crossing, swinging, or shifting weight from foot to foot. This usually develops within four weeks of starting the medication.
- Parkinsonism: tremor, stiffness, and slowed movement that mimic Parkinson’s disease symptoms.
- Tardive dyskinesia: involuntary, repetitive movements of the face, tongue, and sometimes limbs. This is a concern with longer-term use and can sometimes persist even after stopping the medication.
Drowsiness is also very common, given the medication’s effect on histamine receptors. Dry mouth, constipation, and blurred vision can occur as well.
Who Should Avoid It
Prochlorperazine is not safe for everyone. People with Parkinson’s disease face a particular risk because the medication blocks the same dopamine pathways that are already depleted in Parkinson’s, potentially worsening symptoms dramatically. It also interacts with levodopa and other Parkinson’s medications.
Other conditions that require caution or may rule out prochlorperazine include dementia, seizure disorders, liver disease, heart rhythm abnormalities, glaucoma, and low blood pressure. It can lower the seizure threshold, worsen glaucoma, and cause dangerous drops in blood pressure.
The medication interacts with a long list of other drugs. Alcohol, sedatives, opioids, certain antidepressants, blood pressure medications, and blood thinners like warfarin can all interact in ways that increase side effects or change how either drug works. A few medications should never be combined with prochlorperazine at all, including metoclopramide (another anti-nausea drug that blocks the same receptors) and certain heart rhythm medications.
Available Forms
Prochlorperazine is available as an oral tablet and a rectal suppository for use at home. In hospital and emergency settings, it can also be given by injection. The suppository form is particularly practical for its main indication, since people dealing with severe vomiting often can’t keep oral medications down. The brand name Compro is still marketed, while the original brand Compazine has been discontinued, though generic versions remain widely available.